Physician profile
Shadi Idris
NPI 1891919312
$7,500.15
in general payments reported to CMS, 2019-2025
19 companies · $3,112 in 2025
The $3,112 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,243 · 2020: $36.37 · 2021: $180 · 2022: $1,245 · 2023: $332 · 2024: $351 · 2025: $3,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,215 · Travel and Lodging: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,214.61 |
| Travel and Lodging | $1,581.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,585.75 | 2019-2025 | Farapulse, Watchman Flx, Emblem Mri S-Icd |
| Abbott Laboratories | $902.42 | 2019-2025 | Amplatzer Amulet, Advisor, Allure |
| Medical Device Business Services, INC. | $892.76 | 2019 | |
| Medtronic Vascular, INC. | $660.47 | 2019-2020 | |
| Medtronic, INC. | $409.00 | 2023-2025 | Micra, Affera Mapping System, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $237.13 | 2019-2024 | Carto 3 |
| Philips North America LLC | $216.82 | 2019-2025 | Igt Devices Undivided, Lm Undivided |
| Biotronik INC. | $169.24 | 2022 | |
| Kestra Medical Technology Services, INC. | $89.17 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.17 | 2019-2025 | Lifevest |
| Stryker Corporation | $50.70 | 2025 | Artix Mt |
| Atricure, INC. | $36.67 | 2023 | |
| Novartis Pharmaceuticals Corporation | $35.77 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.48 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $26.93 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $19.79 | 2023 | |
| Pfizer INC. | $18.06 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.38 | 2025 | Eliquis |
| Amgen INC. | $15.44 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shadi Idris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.